Abstract
HIV-1 infects target cells via a receptor complex formed by CD4 and a chemokine receptor, primarily CCR5 or CXCR4 (ref. 1). Commonly, HIV-1 transmission is mediated by CCR5-tropic variants, also designated slow/low, non-syncytia-inducer or macrophage-tropic, which dominate the early stages of HIV-1 infection and frequently persist during the entire course of the disease2,3,4,5,6,7,8,9. In contrast, HIV-1 variants that use CXCR4 are typically detected at the later stages, and are associated with a rapid decline in CD4+ T cells and progression to AIDS (refs. 2,7–11). Disease progression is also associated with the emergence of concurrent infections that may affect the course of HIV disease by unknown mechanisms. A lymphotropic agent frequently reactivated in HIV-infected patients is human herpesvirus 6 (HHV-6), which has been proposed as a cofactor in AIDS progression12. Here we show that in human lymphoid tissue ex vivo13,14,15, HHV-6 affects HIV-1 infection in a coreceptor-dependent manner, suppressing CCR5-tropic but not CXCR4-tropic HIV-1 replication, as shown with both uncloned viral isolates and isogenic molecular chimeras. Furthermore, we demonstrate that HHV-6 increases the production of the CCR5 ligand RANTES ('regulated upon activation, normal T-cell expressed and secreted'), the most potent HIV-inhibitory CC chemokine16, and that exogenous RANTES mimics the effects of HHV-6 on HIV-1, providing a mechanism for the selective blockade of CCR5-tropic HIV-1. Our data suggest that HHV-6 may profoundly influence the course of HIV-1 infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berger, E. et al. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism and disease. Ann. Rev. Immunol. 17, 657–700 (1999).
Fenyo, E.M. et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62, 4414–4419 (1988).
Tersmette, M. et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1, 983–5 (1989).
Schuitemaker, H. et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354–60 (1992).
Fenyo, E.M. Viral phenotype and severity of HIV-1 infection: Are children different from adults? AIDS 7, 1673–4 (1993).
Koot, M. et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rates of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118, 681–688 (1993).
Bjorndal, A. et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478–87 (1997).
Scarlatti, G. et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Med. 3, 1259–1265 (1997).
Connor, R.I., Sheridan, K.E., Ceradini, D., Choe, S. & Landau, N.R. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1–infected individuals. J. Exp. Med. 185, 621–628 (1997)
Fouchier, R.A., Meyaard, L., Brouwer, M., Hovenkamp, E. & Schuitemaker, H. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo. Virology 219, 87–95 (1996).
Koot, M. et al. Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. J. Infect. Dis. 179, 254–258 (1999).
Lusso, P. & Gallo, R.C. Human herpesvirus 6 in AIDS. Immunol. Today 16, 67–71 (1995).
Glushakova, S., Baibakov, B., Margolis, L.B. & Zimmerberg, J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nature Med. 1, 1320–1322 (1995).
Glushakova, S., Baibakov, B., Zimmerberg, J. & Margolis, L. Experimental HIV infection of human lymphoid tissue: Correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histoculture inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res.& Hum. Retrovir. 13, 461–471 (1997).
Grivel, J.C. & Margolis, L.B. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Naure Med 5, 344–346 (1999).
Cocchi, F. et al. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811–1815 (1995).
Salahuddin, S.Z. et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234, 596–601 (1986).
Locatelli, G. et al. Real-time quantitative PCR for human herpesvirus 6 DNA. J. Clin. Microbiol. 38, 4042–4048 (2000).
Smyth, R.J., Yi, Y., Singh, A. & Collman, R.G. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J. Virol. 72, 4478–4484 (1998).
Glushakova, S. et al. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J. Clin. Invest. 104, R7–R11 (1999).
Kinter, A.L. et al. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA 93, 14076–14081 (1996).
Margolis, L.B., Glushakova, S., Grivel, J.C. & Murphy, P.M. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. J. Clin. Invest. 101, 1876–1880 (1998).
Gordon, C.J. et al. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J. Virol. 73, 684–94 (1999).
Kinter, A. et al. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4+ T cells: Role of signal transduction. Proc. Natl. Acad. Sci. USA 95, 11880–11885 (1998).
Kelly, M.D., Naif, H.M., Adams, S.L., Cunningham, A.L. & Lloyd, A.R. Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J. Immunol. 160, 3091–3095 (1998).
Dolei, A. et al. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS 12, 183–190 (1998).
Rucker, J. et al. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71, 8999–9007 (1997).
Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M.C. & Cesarman, E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347–350 (1997).
Milne, R.S. et al. RANTES binding and down-regulation by a novel human herpesvirus-6 β chemokine receptor. J. Immunol. 164, 2396–404 (2000).
Xiang, J. et al. Effect of co-infection with GB virus C on survival among patients with HIV infection. N. Engl. J. Med. 345, 707–14 (2001).
Watt, G. et al. HIV-1 suppression during acute scrub-typhus infection. Lancet 356, 475–479 (2000).
Acknowledgements
We thank R. Collman for providing us with 89.6 and 89-v345.SF HIV-1 variants; J. Zimmerberg for his support and encouragement. The work of J.-C.G., Y.I., W.F. and L.M. was supported, in part, by the NASA/NIH Center for Three-Dimensional Tissue Culture. The work of P.L. and M.S.M. was partly supported by Grants from Istituto Superiore di Sanita, Rome, Italy.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Grivel, JC., Ito, Y., Fagà, G. et al. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med 7, 1232–1235 (2001). https://doi.org/10.1038/nm1101-1232
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1101-1232
This article is cited by
-
Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation
BMC Gastroenterology (2019)
-
Multiple sclerosis: an example of pathogenic viral interaction?
Virology Journal (2017)
-
Assessing the variability of Brazilian Vaccinia virus isolates from a horse exanthematic lesion: coinfection with distinct viruses
Archives of Virology (2011)
-
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A
Retrovirology (2009)
-
Use of human tissue explants to study human infectious agents
Nature Protocols (2009)